APA (7th ed.) Citation

Axelrad, J., Forss, A., Söderling, J., Mårild, K., Halfvarson, J., Naucler, P., . . . Group†, ;. S. S. (2026). Risk of serious infections in patients with inflammatory bowel disease treated with biologic and small molecule therapies: A nationwide cohort study. Journal of Crohn's & Colitis, 20(2), 1. https://doi.org/10.1093/ecco-jcc/jjaf229

Chicago Style (17th ed.) Citation

Axelrad, Jordan, Anders Forss, Jonas Söderling, Karl Mårild, Jonas Halfvarson, Pontus Naucler, Jonas F. Ludvigsson, Ola Olén, and ; SWIBREG Study Group†. "Risk of Serious Infections in Patients with Inflammatory Bowel Disease Treated with Biologic and Small Molecule Therapies: A Nationwide Cohort Study." Journal of Crohn's & Colitis 20, no. 2 (2026): 1. https://doi.org/10.1093/ecco-jcc/jjaf229.

MLA (9th ed.) Citation

Axelrad, Jordan, et al. "Risk of Serious Infections in Patients with Inflammatory Bowel Disease Treated with Biologic and Small Molecule Therapies: A Nationwide Cohort Study." Journal of Crohn's & Colitis, vol. 20, no. 2, 2026, p. 1, https://doi.org/10.1093/ecco-jcc/jjaf229.